VALEANT PHARM INTL
Big PharmaVALEANT PHARM INTL is a major pharmaceutical company focused on Dermatology, Immunology, Gastroenterology.
VALEANT PHARM INTL's Key Drugs
VALEANT PHARM INTL's key approved drugs from the last 15 years (excludes generics, biosimilars and IV formulations).
VALEANT PHARM INTL's Recent FDA Approvals
New NDA/BLA approvals for VALEANT PHARM INTL over the last two years — novel drugs only, excluding generics and label supplements.
VALEANT PHARM INTL's Therapeutic Areas
VALEANT PHARM INTL's approved drugs and pipeline span 3 therapeutic areas, led by Dermatology and Immunology, across 0 biologic and 2 small-molecule drugs. Weighted by commercial stage — approved drugs count most, then late-stage trials.
VALEANT PHARM INTL's Top Competitors
VALEANT PHARM INTL's closest competitors by therapeutic-area and drug-target overlap include BAUSCH, Pfizer, and PF PRISM CV. Ranked by overlap in therapeutic areas and drug targets across approved drugs and pipeline.
VALEANT PHARM INTL Pipeline Snapshot
Active clinical trials for VALEANT PHARM INTL across all therapeutic areas, from ClinicalTrials.gov.
Pro Intelligence Preview
Deep insights for investors and analysts
Revenue Insights
- • Top drug revenue breakdown
- • Drug-level revenue analysis
Trial Catalysts
- • Dermatology pipeline focus
- • Phase 3 readout tracking
Patent Risk
- • Patent expiration timeline
- • Revenue at risk analysis
Compare Companies
- • Side-by-side pipeline analysis
- • Revenue & market share comparison
Revenue forecasts • Trial milestones • Patent risk modeling
Active (0)
Discontinued (0)
Company Info
- First Approval
- 1952-11-10
- Latest
- 2016-12-16
- Applications
- 40